ArticleScientific reports2025
Midnight darkness and evening melatonin pre-treatment reverse night-light-induced neurobehavioural disruptions in a diurnal corvid.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Brighter nights, greater health risks: intensity-dependent disruptions by nighttime light exposure on sleep and metabolism in diurnal zebra finches.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026Article
- The ecological importance of natural dark nights for circadian organization, metabolism and reproduction in birds.BMC ecology and evolution · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial light at night (ALAN) is a growing environmental pollutant with significant risks to brain health in both animals and humans. This study assessed the ALAN-induced negative impact and examined potential mitigative strategies on neurobehavioural traits and associated neural pathways in diurnal Indian house crows subjected to dim light at night (dLAN, 6 lx) in a 12-hour:12-hour light-dark cycle. The 12-hour dLAN period was either interrupted midway by a 2-hour dark period (controls in 0 lx dark night; experiment 1) or preceded by a 50 µg day⁻¹ crow⁻¹ melatonin pre-treatment 30 min before the dLAN onset (controls received vehicle; experiment 2). dLAN exposure reduced nocturnal melatonin levels, and negatively impacted the circadian behaviour, sleep, mood and cognitive performance as well as the mRNA expression of genes associated with neurogenesis (bdnf, dcx, nr4a2), neuroinflammation (tnfα and tnfr1), and epigenetic regulation (hat1, hdac2, hdac4) in hippocampus and nidopallium caudolaterale brain regions. The midnight 2-hour dark period partially restored, but the evening melatonin pre-treatment completely restored the dLAN-induced disrupted neurobehaviours and associated gene expressions. These results provide mechanistic insights into night-light pollution effects, and suggest a pivotal role of melatonin in preserving the sleep integrity and cognitive functions in animals, perhaps also in humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.